WILLIAM J DAWSON

CIK 1226139 · Chief Financial Officer · last filed 2026-03-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.24M

Companies

3

Total Filings

58

Lifetime Open-Market Net

-$5.10M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MGRC Director 7,300 $115.09 $840.2K -$5.20M 45 2026-03-03
Adamas Pharmaceuticals Inc (ADMS) Delisted Chief Financial Officer 14,284 $8.22 $117.4K -$12.2K 5 2017-03-22
CERS Chief Financial Officer 156,825 $2.56 $401.5K $108.7K 8 2009-01-14

Recent Filings · Page 6 of 6

58 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-02-27 MGRC Grant (A) $0 EDGAR
2008-01-14 CERS Grant (A) +3,630 $0 EDGAR
2007-10-03 CERS Grant (A) $0 EDGAR
2007-07-02 CERS Grant (A) +25 $0 EDGAR
2007-03-01 MGRC Mixed -$354.8K EDGAR
2007-02-28 CERS Buy (P) +20,000 $108.7K EDGAR
2007-02-28 MGRC Grant (A) $0 EDGAR
2007-01-09 CERS Grant (A) +5,114 $0 EDGAR
Showing 5158 of 58
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.